Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/1998
12/15/1998CA1340246C Use of pyridoxine derivatives in the prevention and treatment of hyperlipidaemia and athersclerosis
12/11/1998CA2233584A1 7tm receptor hlwar77
12/11/1998CA2230998A1 Cdna clone hapoi67 that encodes a human 7-transmembrane receptor
12/10/1998WO1998055638A1 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof
12/10/1998WO1998055620A1 Ntn-2 member of tnf ligand family
12/10/1998WO1998055514A1 Oligosaccharide mixtures having antithrombotic activity
12/10/1998WO1998055506A2 Thrombin-inhibiting peptide
12/10/1998WO1998055483A1 PYRROLO[2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
12/10/1998WO1998055481A1 Benzonaphthyridine
12/10/1998WO1998055475A1 Guanidine deriviatives as inhibitors of na+/h+ exchange in cells
12/10/1998WO1998055474A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application
12/10/1998WO1998055472A1 Coumarin derivatives, methods of preparation and application as medicines
12/10/1998WO1998055142A1 Methods for treating thrombotic disorders
12/10/1998WO1998055134A1 Treatment of heart failure with growth hormone
12/10/1998WO1998055124A1 (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
12/10/1998WO1998055074A2 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
12/10/1998WO1998054962A1 Anti-arrhythmic composition and methods of treatment
12/10/1998WO1998035967A3 Biazacyclic crf antagonists
12/10/1998DE19724791A1 Thrombin hemmende Peptide Thrombin inhibitory peptides
12/10/1998CA2293587A1 Oligosaccharide mixtures having antithrombotic activity
12/10/1998CA2293429A1 Methods for treating thrombotic disorders
12/10/1998CA2293265A1 Anti-arrhythmic composition and methods of treatment
12/10/1998CA2292668A1 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
12/10/1998CA2291153A1 Benzonaphthyridine
12/10/1998CA2290695A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application
12/09/1998EP0882793A2 A human 7-tm receptor similar to murine frizzled-6 gene
12/09/1998EP0882791A2 WNT-11 polypeptides
12/09/1998EP0882737A1 Ligated d-protein and method of indentifying compounds that modulate receptor activity
12/09/1998EP0882719A1 Arylethenesulfonamide derivatives and drug composition containing the same
12/09/1998EP0882718A1 Benzimidazole derivatives
12/09/1998EP0882717A1 Nitrogenous heterocyclic compounds
12/09/1998EP0882453A2 Methods for treating thrombotic disorders
12/09/1998EP0882450A2 Cholesterol-lowering composition comprising coenzyme Q
12/09/1998EP0882044A1 1,4-dihydropyridine compounds as bradykinin antagonists
12/09/1998EP0882039A1 Endothelin receptor antagonists
12/09/1998EP0882031A1 Novel benzoyl guanidine derivatives, process for their preparation and their use in the preparation of medicines
12/09/1998EP0712390B1 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors
12/09/1998EP0689599B1 Chimeric selectins by exchange of domains - uses thereof
12/09/1998EP0628052B1 Alkali metal 8,9-dehydroestrone sulfate esters
12/09/1998CN1201458A (-) cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-1-ylethoxy) phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate
12/09/1998CN1200930A Medicinal liquor for body-building and treating rheumatism
12/09/1998CN1041090C Pyridopyrimidine derivatives, their production and use
12/08/1998US5847093 Human apoptosis regulator
12/08/1998US5847086 Therapeutic fragments of von Willebrand factor
12/08/1998US5847007 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
12/08/1998US5847000 Fatty acid derivatives
12/08/1998US5846990 Substituted biphenyl isoxazole sulfonamides
12/08/1998US5846988 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
12/08/1998US5846975 Use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence
12/08/1998US5846967 Natriuretic and anti-hypertensive compounds
12/08/1998US5846966 Combinations of hydroxy-substituted azetidinone compounds and HMG CoA Reductase Inhibitors
12/08/1998US5846959 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
12/08/1998US5846755 Method for determining the therapeutic activity of metalloproteinase inhibitor compounds
12/08/1998US5846566 Microcapsules for the controlled release of acetylsalicylic acid in the gastrointestinal environment
12/08/1998US5846514 Enhancement of the efficacy of nifedipine by deuteration
12/08/1998CA2053209C Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
12/03/1998WO1998054572A1 Methods for evaluating tissue morphogenesis and activity
12/03/1998WO1998054316A1 Sodium channel receptor
12/03/1998WO1998054301A2 Transplants for myocardial scars and method and cellular preparations therefor
12/03/1998WO1998054222A1 Cyclic crf agonists
12/03/1998WO1998054216A1 Gene and amino acid sequences for novel transcription factor
12/03/1998WO1998054211A2 Cyclodepsipeptides and pharmaceutical compositions containing them
12/03/1998WO1998054199A1 Tissue plasminogen activator-like protease
12/03/1998WO1998054190A1 Novel compounds
12/03/1998WO1998054187A1 Spiro-azacyclic derivatives and their use as therapeutic agents
12/03/1998WO1998054181A1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors
12/03/1998WO1998054180A1 Novel compounds
12/03/1998WO1998054170A1 SUBSTITUTED 2-(2,6-DIOXOPIPERIDIN-3-YL)-PHTHALIMIDES AND 1-OXOISOINDOLINES AND METHOD OF REDUCING TNFα LEVELS
12/03/1998WO1998054166A1 A new salt
12/03/1998WO1998054158A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES
12/03/1998WO1998054157A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p561ck TYROSINE KINASES
12/03/1998WO1998054156A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56lck TYROSINE KINASES
12/03/1998WO1998054153A1 Novel cyclic diamine compounds and medicine containing the same
12/03/1998WO1998054149A1 Process for obtaining quinapryl hydrochloride and solvates useful for isolating and purifying quinapryl hydrochloride
12/03/1998WO1998054093A1 Novel angiogenesis inhibitors
12/03/1998WO1998053846A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
12/03/1998WO1998053840A1 SIALOADHESIN FAMILY 4 cDNA
12/03/1998WO1998053834A1 Use of low-molecular-weight heparins for preventing and treating cerebral edemas
12/03/1998WO1998053832A1 Use of hypothalmic inhibitory factor in the treatment of ischemic cardiac malfunction
12/03/1998WO1998053823A1 5-HT1A AND 5-HT1Dα ANTAGONISTS
12/03/1998WO1998053821A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-β1
12/03/1998WO1998053818A1 Sulfonamides as cell adhesion inhibitors
12/03/1998WO1998053817A1 Biarylalkanoic acids as cell adhesion inhibitors
12/03/1998WO1998053816A1 Method of treating isolated systolic hypertension
12/03/1998WO1998053814A1 Heterocyclic amide compounds as cell adhesion inhibitors
12/03/1998WO1998042739A3 Secreted proteins and polynucleotides encoding them
12/03/1998DE19719652A1 Use of tissue factor
12/03/1998CA2291778A1 Heterocyclic amide compounds as cell adhesion inhibitors
12/03/1998CA2291774A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/03/1998CA2291762A1 Biarylalkanoic acids as cell adhesion inhibitors
12/03/1998CA2291750A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/03/1998CA2291728A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/03/1998CA2291709A1 Novel angiogenesis inhibitors
12/03/1998CA2291708A1 Sulfonamides as cell adhesion inhibitors
12/03/1998CA2291674A1 5-ht1a and 5-ht1d.alpha. antagonists
12/03/1998CA2291484A1 Gene and amino acid sequences for novel transcription factor
12/03/1998CA2291482A1 Tissue plasminogen activator-like protease
12/03/1998CA2290682A1 Use of low-molecular-weight heparins for preventing and treating cerebral edemas
12/03/1998CA2289037A1 Spiro-azacyclic derivatives and their use as therapeutic agents
12/02/1998EP0881294A2 HOEFCC11, a HAS2 splicing variant
1 ... 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 ... 1595